Neurocrine Biosciences, Inc. (NBIX)
127.68
-2.51
(-1.93%)
USD |
NASDAQ |
Apr 24, 16:00
129.98
+2.30
(+1.80%)
After-Hours: 07:37
Neurocrine Biosciences Price : 127.68 for April 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Soleno Therapeutics, Inc. | 52.72 |
| Glaukos Corp. | 121.48 |
| Edgewise Therapeutics, Inc. | 31.58 |
| Nuvalent, Inc. | 104.50 |
| Biogen, Inc. | 184.38 |
Price Related Metrics
| PE Ratio | 27.35 |
| PS Ratio | 4.572 |
| PEG Ratio | 0.6539 |
| Price to Book Value | 3.939 |
| Price to Free Cash Flow | 17.47 |
| Earnings Yield | 3.66% |
| Market Cap | 12.81B |
| PEGY Ratio | 0.6539 |
| Operating PE Ratio | 20.55 |
| Normalized PE Ratio | 26.53 |